✨ Health Notices




NEW ZEALAND GAZETTE

No. 11


Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Mesalazine 16.67% (500 mg) Suppository, rectal Montefarmaco SpA., Pero (Milano), Italy Asacol
Benzoyl peroxide 50 mg/mL in 200 mL Solution, topical Galderma Laboratories, de Montdesir, Alby Sur Cheran, France Benzac AC Wash 5%
Pyrantel embonate equivalent to 100 mg pyrantel base per square Chocolate, medicated Mentholatum Australasia Pty Limited, Scoresby, Victoria, Australia Combantrin Chocolate Squares

Dated this 30th day of January 1997.

KAREN O. POUTASI (Dr), Director-General of Health, pursuant to delegation given by the Minister of Health on 18 January 1996.

go770


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Sodium acid phosphate 1 mmol/mL in 20 mL Injection, ampoule McGaw Biomed Limited, Point Chevalier, Auckland
Methadone hydrochloride 10 mg/mL in 100 mL, 200 mL, 500 mL Solution, oral McGaw Biomed Limited, Point Chevalier, Auckland Biodone Extra Forte
Methadone hydrochloride 5 mg/mL in 100 mL, 200 mL, 500 mL Solution, oral McGaw Biomed Limited, Point Chevalier, Auckland Biodone Forte
Adrenaline 1 mg/mL in 0.3 mL Injection, prefilled syringe Meridian Medical Technologies Inc., St. Louis, Missouri, United States of America EpiPen Auto Injector
Adrenaline 0.5 mg/mL in 0.3 mL Injection, prefilled syringe Meridian Medical Technologies Inc., St. Louis, Missouri, United States of America EpiPen Jr Auto Injector
Cajuput oil 0.5%, camphor 3.5%, capsicum 0.15%, eucalyptus oil 3.0%, menthol 5.0%, methyl salicylate 20.0%, peppermint oil 0.5%, pine oil 1.0%, turpentine 1.0% Cream, skin Herron Pharmaceuticals Pty Limited, Tennyson, Queensland, Australia Goanna Heat Cream
Benzalkonium chloride 0.1% w/w, tolnaftate 1.0% w/w Cream The Boots Company plc., Nottingham, United Kingdom Mycota
Chlorhexidine hydrochloride 0.25 w/w, tolnaftate 1.0% w/w Powder The Boots Company plc., Nottingham, United Kingdom Mycota
Chlorpheniramine maleate 1 mg, dextromethorphan hydrobromide 7.5 mg per 5 mL in 100 mL Syrup Sigma Pharmaceuticals Pty Limited, Clayton, Victoria, Australia Orthoxicol for Children Nightrest Cough Mixture
Azelastine hydrochloride 0.1% w/v in 10 mL Spray, nasal metered Asta Medica AG., Frankfurt, Germany Rhinolast


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1997, No 11


NZLII PDF NZ Gazette 1997, No 11





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
30 January 1997
Medicines Act 1981, Changed Medicines, Consent, Distribution, Mesalazine, Benzoyl Peroxide, Pyrantel Embonate
  • KAREN O. POUTASI (Dr), Director-General of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
30 January 1997
Medicines Act 1981, New Medicines, Consent, Distribution, Sodium Acid Phosphate, Methadone Hydrochloride, Adrenaline, Cajuput Oil, Benzalkonium Chloride, Chlorhexidine Hydrochloride, Chlorpheniramine Maleate, Azelastine Hydrochloride
  • KAREN O. POUTASI (Dr), Director-General of Health